Reduced
0.09% → 0.08%
Oaktree Capital sold 1,523,000 shares; portfolio weight moved from 0.09% to 0.08%.
-1,523,000 Shares
-21.46%
NEOGENOMICS INC is tracked here as a normalized 13F company record; no curated business description is available yet.
Original CUSIPs: 64049MAB6. This page shows current managers, quarterly changes, and primary SEC sources.
Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.
Oaktree Capital sold 1,523,000 shares; portfolio weight moved from 0.09% to 0.08%.
Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.
Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.
| Quarter | Current managers | Combined value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 1 | $3,279,566 | 3,819,000 | Oaktree Capital New position · 3,819,000 Shares |
| Q3 2025 | 1 | $3,399,450 | 3,930,000 | Oaktree Capital Increased · 3,930,000 Shares |
| Q4 2025 | 1 | $6,343,837 | 7,098,000 | Oaktree Capital Increased · 7,098,000 Shares |
| Q1 2026 | 1 | $5,101,124 | 5,575,000 | Oaktree Capital Reduced · 5,575,000 Shares |
| Manager | Issuer | CUSIP | Security class | Market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Oaktree Capital | NEOGENOMICS INC | 64049MAB6 | CONVERTIBLE BOND | $5,101,124 | 5,575,000 | 0.08% | SEC XML |